Key facts
- This page summarizes Steven Sandor's Form 4 filing for BIOLASE, INC (BIOLQ).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 06 Jun 2023, 20:37.
Steven Sandor - 02 Jun 2023 Form 4 Insider Report for BIOLASE, INC (BIOLQ)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- BIOLQ
- Reported as of
- 02 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2023, 20:37:20 UTC
- Prior SEC filing
- 12 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael C. Carroll, attorney-in-fact for Steven Sandor
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Steven Sandor filed Form 4 for BIOLASE, INC (BIOLQ) on 06 Jun 2023.
Change
- Previous filing in this sequence was filed on 12 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIOL
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +58,000
- Change %
- +198%
- Price
- $0.000000
- Shares after
- 87,265
- Date
- 02 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,000
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
Footnote F2
The restricted stock unit award vests as follows: (i) one-half of the restricted stock units shall vest on May 9, 2024, and (ii) one-half of the restricted stock units shall vest on May 9, 2025, subject to the Reporting Person's continued service with the Company.